Company intelligence / Profile preview

Pannacean

Zhengzhou, Henan, Chinaen.pannacean.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Pannacean specializes in the research, development, and supply of active pharmaceutical ingredients (APIs), drug metabolites, key intermediates, innovative nucleosides, phosphoramidite monomers for oligonucleotide/RNA synthesis, and related substances[1][2]. The company supports partners in small molecule and biomolecule drug development by providing high-quality building blocks but does not have its own clinical pipeline.

Modalities: Small moleculeNucleoside analogsOligonucleotide monomersRNA-based drugs (enabling technology)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Pannacean.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pannacean.

Explore the full profile